Defective Drug Lawyer Atlanta – Holding Pharmaceutical Companies Accountable

Americans trust that the prescription and over-the-counter medications they take are safe, effective, and properly labeled. When a pharmaceutical company puts a dangerous drug on the market – one that causes serious side effects, organ damage, cancer, or death – the consequences extend far beyond a single patient. Defective drugs harm thousands of people before regulators even begin investigating, and the pharmaceutical industry’s financial power means that injured patients face an uphill battle to hold these companies accountable.

At Wetherington Law Firm, our Atlanta defective drug lawyers represent individuals and families who have been harmed by dangerous medications, unreported side effects, contaminated drugs, and improperly marketed pharmaceuticals. We understand the complex intersection of federal FDA regulation, Georgia product liability law, and the scientific evidence required to prove that a drug caused your injury. Our attorneys have the resources to take on major pharmaceutical manufacturers and fight for the compensation our clients deserve.

If you or a loved one has suffered serious side effects or injury from a prescription drug, over-the-counter medication, or medical supplement, our attorneys can evaluate your case and determine whether you have a viable product liability claim under Georgia law.

Georgia Product Liability Law and Defective Drugs

Georgia’s product liability framework provides several legal theories under which a person injured by a defective drug can pursue compensation. Understanding these theories is critical because the legal strategy in a pharmaceutical liability case depends on the specific type of defect involved and how the drug reached the market.

Strict Liability Under O.C.G.A. § 51-1-11

Under Georgia’s strict liability statute, O.C.G.A. § 51-1-11, a manufacturer of a product – including a pharmaceutical company – is liable for injuries caused by a defective product regardless of whether the manufacturer was negligent. This means the injured person does not need to prove that the drug company was careless or made a mistake. Instead, the focus is on whether the drug itself was defective and whether that defect caused the injury.

Georgia has adopted the Restatement (Third) of Torts: Products Liability framework, which categorizes product defects into three types. Each type of defect creates a different legal theory for holding the pharmaceutical company liable.

Three Types of Drug Defects

1. Design Defects

A design defect exists when the drug’s chemical formulation or molecular design is inherently dangerous – meaning the drug is unreasonably dangerous even when manufactured correctly and used as directed. In pharmaceutical cases, design defect claims argue that the drug should never have been formulated the way it was because the risks outweigh the benefits.

Georgia courts evaluate design defect claims using a risk-utility analysis. The court considers whether a reasonable alternative design existed that would have reduced or eliminated the risk without significantly compromising the drug’s therapeutic benefit. Factors include:

• The severity and likelihood of harm from the drug’s design
• Whether the drug’s benefits outweigh its risks for the intended patient population
• The availability of alternative drugs or formulations that provide similar therapeutic benefit with lower risk
• The feasibility of designing the drug differently
• Whether the drug’s design met or exceeded industry standards at the time of manufacture

Design defect claims in pharmaceutical cases are particularly complex because most drugs carry some inherent risk. The question is not whether the drug has side effects, but whether the overall risk-benefit profile renders the drug unreasonably dangerous.

2. Manufacturing Defects

A manufacturing defect occurs when a specific batch or lot of a drug deviates from the intended design or formulation. This can include contamination, incorrect dosing, impurities, wrong ingredients, or errors in the manufacturing process that make a particular batch of the drug more dangerous than the properly manufactured version.

Manufacturing defect claims are often more straightforward than design defect claims because the plaintiff simply needs to show that the drug they received differed from the manufacturer’s own specifications. Common examples include:

• Contamination: Foreign substances, bacteria, or other impurities introduced during manufacturing
• Incorrect dosage: Pills or capsules containing more or less of the active ingredient than specified
• Cross-contamination: Traces of another drug present in the medication due to shared manufacturing equipment
• Degradation: Drug that has broken down or become unstable due to improper manufacturing, storage, or handling
• Compounding errors: Mistakes made by compounding pharmacies that prepare customized medications

3. Marketing Defects (Failure to Warn)

Marketing defect claims – also known as failure-to-warn claims – are the most common type of claim in defective drug litigation. A marketing defect exists when the pharmaceutical company fails to provide adequate warnings about the drug’s known risks, fails to include proper usage instructions, or markets the drug in a misleading way that understates its dangers.

Under Georgia law, a drug manufacturer has a duty to warn both prescribing physicians and consumers about known risks associated with its products. Failure-to-warn claims allege that if the pharmaceutical company had provided adequate warnings, the doctor would not have prescribed the drug or the patient would not have taken it. Common failure-to-warn scenarios include:

• Failing to disclose known serious side effects on the drug label
• Understating the frequency or severity of adverse reactions
• Failing to update warnings when new safety data becomes available
• Marketing a drug for off-label uses without disclosing the risks of those uses
• Concealing or suppressing unfavorable clinical trial data
• Providing misleading information to physicians through sales representatives

The Learned Intermediary Doctrine in Georgia

Georgia follows the learned intermediary doctrine, which holds that a pharmaceutical company’s duty to warn runs primarily to the prescribing physician rather than directly to the patient. Under this doctrine, the pharmaceutical company satisfies its warning obligation by providing adequate warnings to the doctor, who then uses professional judgment to decide whether to prescribe the drug and what to tell the patient.

This doctrine has important implications for defective drug cases. If the pharmaceutical company provided adequate warnings to the prescribing physician and the physician prescribed the drug anyway, the company may argue it fulfilled its warning duty. However, the doctrine does not protect a company that:

• Failed to warn physicians about known risks
• Provided incomplete or misleading information to physicians
• Marketed the drug directly to consumers (direct-to-consumer advertising may bypass the learned intermediary doctrine in some circumstances)
• Suppressed safety data that would have changed physicians’ prescribing decisions

The Role of the FDA in Defective Drug Cases

The U.S. Food and Drug Administration (FDA) is the federal agency responsible for regulating the development, testing, approval, manufacturing, and marketing of pharmaceutical drugs. Understanding the FDA’s role is important because pharmaceutical companies frequently argue that FDA approval of a drug should shield them from product liability claims.

The FDA Approval Process

Before a new drug can be sold in the United States, the manufacturer must submit a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) to the FDA demonstrating that the drug is safe and effective for its intended use. The approval process typically includes:

1. Preclinical testing: Laboratory and animal studies to assess basic safety and identify potential risks
2. Phase I clinical trials: Small-scale studies in healthy volunteers to evaluate safety and determine dosing
3. Phase II clinical trials: Moderate-scale studies in patients with the target condition to evaluate effectiveness and side effects
4. Phase III clinical trials: Large-scale studies comparing the drug to existing treatments or placebo to confirm safety and efficacy
5. FDA review and approval: The FDA reviews all submitted data and decides whether to approve the drug for sale
6. Phase IV post-market surveillance: Ongoing monitoring of the drug’s safety after it enters the market

Why FDA Approval Does Not Prevent Lawsuits

Pharmaceutical companies frequently argue that because the FDA approved their drug, they should be immune from product liability claims. However, FDA approval does not prevent a defective drug lawsuit in Georgia for several important reasons:

• FDA reliance on manufacturer data: The FDA relies heavily on the pharmaceutical company’s own clinical trial data when making approval decisions. If the company submitted incomplete, misleading, or fraudulent data, the approval was based on flawed information
• Limited pre-market testing: Clinical trials involve relatively small numbers of patients over limited periods. Rare side effects and long-term risks may not appear until millions of people take the drug over many years
• Post-approval safety signals: Many dangerous side effects are discovered only after the drug is already on the market through adverse event reports, epidemiological studies, and real-world use
• FDA does not conduct independent testing: The FDA reviews the manufacturer’s data but does not independently test the drug. The manufacturer controls the design, conduct, and reporting of clinical trials
• Regulatory standards differ from liability standards: FDA approval establishes that a drug met minimum regulatory requirements for marketing, not that the drug is safe for all patients or that its manufacturer has no liability for injuries

FDA Safety Communications and Drug Recalls

When the FDA identifies serious safety issues with a marketed drug, it may take several actions, including:

• Black Box Warnings: The most serious FDA warning, required on the drug’s labeling to alert physicians and patients to life-threatening risks
• Safety Communications: Public advisories about newly identified risks associated with marketed drugs
• Risk Evaluation and Mitigation Strategies (REMS): Special programs that may restrict distribution or require additional monitoring for high-risk drugs
• Drug Recalls: Removal of a drug from the market due to contamination, manufacturing defects, or newly discovered safety issues. Recalls can be voluntary (initiated by the manufacturer) or mandated by the FDA
• Market Withdrawal: Complete removal of a drug from the U.S. market when the risks outweigh the benefits for all intended patient populations

An FDA safety communication, black box warning, or recall involving a drug you took is strong evidence supporting a defective drug claim. These actions demonstrate that the drug posed risks that the manufacturer either knew about or should have known about and failed to adequately warn about.

Types of Defective Drug Cases We Handle

Our Atlanta defective drug lawyers represent clients harmed by a wide range of dangerous pharmaceutical products, including:

Dangerous Prescription Drugs

Prescription drugs are the most common source of pharmaceutical liability claims because they often carry significant risks that must be balanced against their therapeutic benefits. We handle cases involving drugs that caused:

• Organ damage: Liver failure, kidney damage, heart damage, or lung injury caused by toxic drug effects
• Cardiovascular events: Heart attacks, strokes, blood clots, or dangerous heart arrhythmias
• Cancer: Drugs linked to increased cancer risk, including certain heartburn medications, diabetes drugs, and blood pressure medications
• Neurological damage: Nerve damage, seizures, movement disorders, or cognitive impairment
• Gastrointestinal injuries: Severe gastrointestinal bleeding, bowel perforation, or pancreatitis
• Birth defects: Drugs taken during pregnancy that cause congenital abnormalities, developmental delays, or fetal death
• Suicidal ideation: Psychiatric medications that increase the risk of suicidal thoughts and behavior
• Addiction and dependency: Drugs that are more addictive than disclosed, including opioid painkillers

Defective Over-the-Counter Medications

Over-the-counter (OTC) drugs are available without a prescription, but they are not without risks. OTC medication manufacturers have a duty to provide accurate labeling, appropriate dosing instructions, and clear warnings about potential side effects and drug interactions. OTC drug liability cases may involve:

• Products containing hidden active ingredients not listed on the label
• Products with dosing errors that lead to accidental overdose
• Products that interact dangerously with common prescription medications
• Products contaminated during manufacturing
• Products marketed with misleading safety claims

Defective Generic Drugs

Generic drugs present unique legal challenges in product liability litigation. Under the U.S. Supreme Court’s decision in PLIVA, Inc. v. Mensing (2011), generic drug manufacturers are generally preempted from state failure-to-warn claims because federal law requires generic drug labels to match the brand-name drug’s label exactly. However, generic drug manufacturers may still be liable for:

• Manufacturing defects: Errors in the manufacturing process that deviate from the approved formulation
• Design defects: Claims that the drug’s formulation is inherently defective (though these are rare in the generic context)
• Failure to update warnings: Under the FDA’s Changes Being Effected (CBE) process, manufacturers may have an obligation to strengthen warnings in certain circumstances

The preemption issue makes it critical to identify the correct manufacturer and determine whether the plaintiff took the brand-name or generic version of the drug. Our attorneys carefully investigate these issues to maximize our clients’ legal options.

Contaminated or Recalled Drugs

Drug contamination cases arise when manufacturing failures introduce harmful substances into pharmaceutical products. These cases often affect large numbers of people and may lead to FDA recalls. We handle cases involving:

• Drugs contaminated with carcinogens (cancer-causing impurities such as NDMA or NDEA)
• Drugs containing higher or lower doses of active ingredient than labeled
• Drugs contaminated with bacteria, mold, or other biological agents
• Compounding pharmacy errors that result in contaminated or improperly formulated medications

Dangerous Dietary Supplements

Dietary supplements, including vitamins, herbal products, and weight-loss supplements, are regulated differently than prescription drugs. Under the Dietary Supplement Health and Education Act (DSHEA), supplements do not require FDA pre-market approval, which means many supplements reach consumers without rigorous safety testing. When supplements cause injury, product liability claims may be based on:

• Hidden pharmaceutical ingredients in supplements marketed as “natural”
• Contamination with heavy metals, pesticides, or other toxins
• Misleading marketing claims about safety or efficacy
• Failure to warn about drug interactions or contraindications

Georgia’s Statute of Limitations for Defective Drug Claims

Understanding the applicable statute of limitations is critical in defective drug cases because many drug injuries develop gradually over months or years, creating questions about when the limitations period begins to run.

The Two-Year Statute of Limitations (O.C.G.A. § 9-3-33)

Under O.C.G.A. § 9-3-33, the general statute of limitations for personal injury claims in Georgia is two years from the date the injury occurred. In product liability cases involving defective drugs, this means two years from the date you were injured by the drug or, in some cases, from the date you discovered (or should have discovered) the connection between your injury and the drug.

The Discovery Rule

The discovery rule can be particularly important in defective drug cases. Drug injuries often develop slowly and may not be immediately apparent. A patient who takes a medication for years may not connect a new health problem to the drug until a doctor identifies the link or the FDA issues a safety warning. Under the discovery rule, the statute of limitations may begin running from the date the plaintiff discovered or reasonably should have discovered that their injury was caused by the defective drug.

The Statute of Repose (O.C.G.A. § 51-1-11(b))

Georgia’s product liability statute includes a ten-year statute of repose under O.C.G.A. § 51-1-11(b). This sets an absolute outer deadline for filing a product liability claim, generally running from the date the product was first sold. However, the statute of repose does not apply in cases involving:

• Willful, reckless, or wanton disregard for life or property
• Fraudulent concealment of a defect
• Breach of an express warranty

In pharmaceutical cases, if the drug company knew about dangers and concealed them – a common allegation in defective drug litigation – the statute of repose may not bar the claim.

Wrongful Death Claims

If a loved one died as a result of taking a defective or dangerous drug, the family may bring a wrongful death claim under O.C.G.A. § 51-4-1. The wrongful death statute of limitations is two years from the date of death.

Comparative Negligence in Defective Drug Cases (O.C.G.A. § 51-12-33)

Georgia follows a modified comparative negligence system under O.C.G.A. § 51-12-33. Under this rule, an injured person’s compensation is reduced by their percentage of fault, and if the person is 50% or more at fault, they are barred from recovery entirely.

In defective drug cases, pharmaceutical companies may raise comparative negligence defenses, arguing that the plaintiff:

• Failed to follow prescribing instructions or dosing guidelines
• Continued taking the drug despite experiencing warning symptoms
• Failed to inform their doctor of relevant medical history or other medications
• Obtained the drug through illegitimate channels
• Used the drug for purposes other than those prescribed

Our attorneys work to counter these defenses by demonstrating that the pharmaceutical company’s defective product – not the plaintiff’s conduct – was the primary cause of the injury. Even if some comparative negligence applies, the plaintiff can still recover damages if their fault is less than 50%.

Damages in Georgia Defective Drug Cases

Victims of defective drugs may be entitled to recover both economic and non-economic damages, and in some cases, punitive damages designed to punish the pharmaceutical company for egregious conduct.

Economic Damages

• Medical expenses: Past and future medical bills, including hospitalizations, surgeries, specialist care, diagnostic testing, rehabilitation, and prescription medications needed to treat the drug injury
• Lost wages: Income lost during recovery and treatment
• Diminished earning capacity: Reduction in future earning ability if the drug injury causes permanent disability or chronic health conditions
• Out-of-pocket costs: Transportation to medical appointments, home modifications, and other expenses directly related to the injury

Non-Economic Damages

• Pain and suffering: Physical pain and emotional distress caused by the drug injury
• Mental anguish: Anxiety, depression, fear, and psychological trauma
• Loss of enjoyment of life: Inability to participate in activities and relationships you enjoyed before the injury
• Loss of consortium: Impact on your relationship with your spouse
• Disfigurement: Scarring or physical changes resulting from the drug injury or necessary medical treatment

Punitive Damages

Punitive damages may be awarded in defective drug cases when the pharmaceutical company’s conduct was particularly egregious. Under O.C.G.A. § 51-12-5.1, punitive damages are available when the defendant acted with willful misconduct, malice, fraud, wantonness, oppression, or conscious indifference to consequences. In pharmaceutical cases, punitive damages are often sought when evidence shows that the company:

• Concealed known safety risks from the FDA, physicians, or the public
• Manipulated or suppressed unfavorable clinical trial data
• Continued marketing a drug after learning of serious safety issues
• Prioritized profits over patient safety
• Paid kickbacks to physicians to promote off-label use

Under Georgia law, punitive damages are generally capped at $250,000 unless the defendant acted with specific intent to cause harm or was under the influence of drugs or alcohol. However, the cap does not apply to product liability cases in which the manufacturer acted with the intent to cause harm.

Multidistrict Litigation (MDL) and Class Actions

Many defective drug cases involve thousands of injured plaintiffs filing claims against the same pharmaceutical manufacturer. These cases are often consolidated into multidistrict litigation (MDL) in federal court to improve efficiency and consistency.

How MDL Works

When numerous federal lawsuits involving the same defective drug are filed across the country, the Judicial Panel on Multidistrict Litigation (JPML) may transfer all related cases to a single federal court for coordinated pretrial proceedings. This consolidation allows:

• Unified discovery against the pharmaceutical manufacturer
• Consistent rulings on common legal issues
• Selection of “bellwether” cases that go to trial first, providing benchmarks for settlement negotiations
• Efficient use of judicial resources and reduced costs for all parties

Individual Claims vs. Class Actions

While MDL consolidates cases for pretrial purposes, each plaintiff’s claim remains individual. This is different from a class action, in which a single representative sues on behalf of all injured people. In pharmaceutical cases, individual claims are generally preferred because:

• Each plaintiff’s injuries, medical history, and damages are unique
• Individual claims allow customized trial strategies
• Settlement amounts reflect each plaintiff’s specific losses
• Plaintiffs retain more control over their cases

Our attorneys evaluate each client’s case individually and recommend whether filing in federal MDL or Georgia state court best serves the client’s interests.

Proving Causation in Defective Drug Cases

Proving that a defective drug caused a specific injury is one of the most challenging aspects of pharmaceutical litigation. Drug companies invest heavily in disputing causation because it is often the weakest link in the plaintiff’s case.

General Causation

General causation asks whether the drug is capable of causing the type of injury the plaintiff experienced. This is established through epidemiological studies, clinical trials, adverse event reports, and scientific literature showing a statistical association between the drug and the injury. Expert witnesses – typically epidemiologists, toxicologists, and pharmacologists – present this scientific evidence to the court.

Specific Causation

Specific causation asks whether the drug actually caused this particular plaintiff’s injury. This requires medical expert testimony establishing that, more likely than not, the plaintiff’s injury was caused by the drug rather than by other factors such as pre-existing conditions, genetic predisposition, lifestyle factors, or other medications.

The Daubert Standard

Expert testimony in pharmaceutical cases must satisfy the Daubert standard (adopted in Georgia under O.C.G.A. § 24-7-702), which requires that expert opinions be based on reliable scientific methodology and relevant data. Pharmaceutical companies aggressively challenge plaintiffs’ expert witnesses through Daubert motions, seeking to exclude testimony that does not meet this standard.

Our firm works with nationally recognized medical and scientific experts who specialize in pharmaceutical toxicology, epidemiology, and clinical pharmacology. These experts are experienced in providing testimony that withstands Daubert challenges and persuades juries.

Who Can Be Held Liable for a Defective Drug?

Multiple parties in the pharmaceutical supply chain may bear liability for injuries caused by a defective drug. Our attorneys investigate the full chain of distribution to identify all potentially liable parties, which may include:

• Pharmaceutical manufacturer: The company that designed, formulated, tested, and produced the drug
• Generic drug manufacturer: The company that produces the generic version of the drug (liability may be limited by federal preemption)
• Drug distributor/wholesaler: Companies that distribute pharmaceutical products from the manufacturer to pharmacies and hospitals
• Pharmacy: The retail pharmacy that dispensed the drug, potentially liable for dispensing errors, incorrect dosing, or failure to check for dangerous drug interactions
• Prescribing physician: In some cases, the prescribing doctor may be liable for prescribing a drug with known contraindications for the specific patient or for failing to monitor the patient for known adverse effects
• Compounding pharmacy: Pharmacies that prepare customized medications may be liable for formulation errors, contamination, or improper compounding
• Contract research organization (CRO): Companies hired to conduct clinical trials may be liable if they conducted research negligently or misreported results
• Sales and marketing entities: Companies involved in promoting the drug may share liability for misleading marketing

Steps to Take If You Suspect a Drug Injury

If you believe a prescription drug, over-the-counter medication, or supplement has caused you harm, taking the right steps promptly can protect your health and your legal rights:

1. Seek immediate medical attention: If you are experiencing adverse effects, contact your doctor or go to an emergency room immediately. Your health is the first priority. Tell your medical provider about all medications and supplements you are taking
2. Do not stop taking medication without medical guidance: Abruptly stopping certain medications can be dangerous. Consult your doctor before discontinuing any prescribed drug
3. Preserve the medication: Keep the drug in its original container with the pharmacy label, lot number, and expiration date intact. If the drug has been recalled, do not return it until your attorney advises you to do so
4. Document everything: Keep a detailed record of your symptoms, when they started, what medications you take, and all medical treatment you receive. Save all pharmacy receipts, prescription records, and insurance statements
5. Obtain your complete medical records: Request records from every healthcare provider who has treated you, including records from before you started taking the drug (to establish your baseline health)
6. Report the adverse event: File a report with the FDA’s MedWatch program. This creates an official record of your adverse experience with the drug
7. Contact a defective drug attorney: An experienced pharmaceutical liability attorney can evaluate your case, determine whether the drug caused your injury, and advise you on your legal options

Frequently Asked Questions About Defective Drug Claims in Georgia

How do I know if my injury was caused by a defective drug?

Identifying a drug-related injury requires careful medical evaluation. Signs that your health problem may be related to a medication include: the symptoms began after you started taking the drug, the symptoms improved when you stopped taking the drug, the drug has been subject to FDA warnings or recalls, or your doctor has identified the drug as a potential cause. An attorney can work with medical experts to evaluate whether the drug caused your specific injury.

Can I sue a pharmaceutical company if the drug was FDA-approved?

Yes. FDA approval does not provide pharmaceutical companies with immunity from product liability lawsuits. The FDA relies on the manufacturer’s own clinical trial data, and many serious side effects are not discovered until the drug has been used by millions of people. Georgia law allows product liability claims against drug manufacturers regardless of FDA approval status.

What is the statute of limitations for a defective drug lawsuit in Georgia?

The general statute of limitations is two years from the date of injury under O.C.G.A. § 9-3-33. However, the discovery rule may extend this deadline if you did not know and could not reasonably have known that your injury was caused by the drug. Georgia also has a ten-year statute of repose for product liability claims, though exceptions exist for fraudulent concealment and willful misconduct.

What if I took the generic version of the drug?

Generic drug claims present unique legal challenges due to federal preemption. Under the Supreme Court’s ruling in PLIVA, Inc. v. Mensing, generic drug manufacturers may not be liable for failure-to-warn claims because federal law requires their labels to match the brand-name drug. However, manufacturing defect claims and certain other theories may still apply. An attorney experienced in pharmaceutical litigation can evaluate your options.

How long do defective drug cases take to resolve?

Defective drug cases are typically complex and can take several years to resolve. Cases consolidated in multidistrict litigation (MDL) may take 3 to 7 years or more, depending on the number of plaintiffs, the complexity of the scientific evidence, and whether bellwether trials are conducted. Individual cases filed in Georgia state court may resolve more quickly but still typically take 1 to 3 years.

What compensation can I recover in a defective drug case?

You may recover economic damages (medical expenses, lost wages, diminished earning capacity), non-economic damages (pain and suffering, mental anguish, loss of enjoyment of life), and in some cases, punitive damages. The amount depends on the severity of your injury, the strength of the evidence, and the pharmaceutical company’s conduct.

Do I need to join a class action to file a defective drug claim?

No. Most defective drug cases are filed as individual claims, even when they are consolidated in multidistrict litigation. Individual claims allow your attorney to present evidence specific to your injuries, medical history, and damages. This typically results in compensation that more accurately reflects your individual losses.

How much does it cost to hire a defective drug lawyer?

At Wetherington Law Firm, we handle all defective drug cases on a contingency fee basis. You pay no attorney fees unless we recover compensation for you. We also advance all costs associated with your case, including expert witness fees, medical record retrieval, and filing costs. Your initial consultation is free and carries no obligation.

Contact Our Atlanta Defective Drug Lawyers for a Free Case Evaluation

If you or a loved one has been harmed by a dangerous or defective drug in Atlanta or anywhere in Georgia, Wetherington Law Firm is ready to evaluate your case and fight for the compensation you deserve. Our experienced defective drug attorneys have the resources, scientific knowledge, and legal skill to take on major pharmaceutical companies and pursue maximum compensation for our clients.

We handle all defective drug cases on a contingency fee basis, meaning you pay no attorney fees unless we recover compensation for you. We advance all costs, including expert witness fees and medical record retrieval. There is no cost and no obligation to speak with our attorneys about your case.

Wetherington Law Firm represents defective drug injury victims throughout Georgia, including Atlanta, Marietta, Decatur, Sandy Springs, Roswell, Alpharetta, Lawrenceville, Duluth, Kennesaw, Smyrna, Macon, Savannah, Augusta, and all surrounding communities. Our attorneys also handle product liability claims, defective medical device cases, wrongful death, and all types of personal injury cases.